However, a recent study aimed to identify the significant prognostic factors of luminal B‐like/ERBB2‐negative EBC in women reported that traditional clinicopathological factors such as age, menopausal status, tumor size, progesterone receptor status, overall histological grade, and Ki‐67 index were not significantly associated with subsequent relapse.5 The gene discussed is MKI67; the disease is neoplasm.